Jim Cramer assesses recent acquisitions in AbbVie and Bristol-Myers

7:35 PM ET Fri, 20 Sept 2019

Jim Cramer breaks down large acquisitions that AbbVie and Bristol-Myers recently made and explains why he's recommending AbbVie as a buy.